Melatonin : Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology - 17(2022), 3-4 vom: 30. Dez., Seite 425-426 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kow, Chia Siang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.01.2023 Date Revised 12.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11481-021-10036-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333872320 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333872320 | ||
| 003 | DE-627 | ||
| 005 | 20231225222534.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11481-021-10036-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1112.xml |
| 035 | |a (DE-627)NLM333872320 | ||
| 035 | |a (NLM)34850335 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kow, Chia Siang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Melatonin |b Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2023 | ||
| 500 | |a Date Revised 12.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Adjuvants, Vaccine |2 NLM | |
| 650 | 7 | |a Melatonin |2 NLM | |
| 650 | 7 | |a JL5DK93RCL |2 NLM | |
| 700 | 1 | |a Ramachandram, Dinesh Sangarran |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Syed Shahzad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology |d 2006 |g 17(2022), 3-4 vom: 30. Dez., Seite 425-426 |w (DE-627)NLM175377324 |x 1557-1904 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g number:3-4 |g day:30 |g month:12 |g pages:425-426 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11481-021-10036-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |e 3-4 |b 30 |c 12 |h 425-426 | ||